The latest news for pharma industry insiders.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

Albert Thigpen, co-founder, Talentwise Consulting, offers highlights of the drug commercialization panel that he participated in.

The latest news for pharma industry insiders.

How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jeffrey Bernstein, director of cybersecurity and data privacy for Kaufman Rossin’s risk advisory services, forecasts how cyber threats could potentially evolve over the next decade.

The latest news for pharma industry insiders.

How does it affect the likelihood of migration?

In the second part of this video interview with Pharma Commerce Editor Nicholas Saraceno, Jeffrey Bernstein, director of cybersecurity and data privacy for Kaufman Rossin’s risk advisory services, outlines some of the common cyber threats faced by healthcare companies.

The latest news for pharma industry insiders.

Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses key takeaways of the breakout session.

The offering will become available in 49 states by next year.

The latest news for pharma industry insiders.

The partnership focuses on the expansion of real-time monitoring and other intelligence services.

In this video interview with Pharma Commerce Editor Nicholas Saraceno, Jeffrey Bernstein, director of cybersecurity and data privacy for Kaufman Rossin’s risk advisory services, explains the top mistakes healthcare organizations make when building and maintaining their software.

The latest news for pharma industry insiders.

With great power comes great responsibility. In this case, tackling these obstacles is vital to making sure that the positives of GLP-1s are not outweighed by the downfalls of improper waste disposal.

A panel dives into the current and future outlook of healthcare policies.

The latest news for pharma industry insiders.

Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses the key takeaways of this year's keynote speech.

Session dives into how healthcare policy implementation impacts stakeholders long-term.

The latest news for pharma industry insiders.

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.

The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.

The latest news for pharma industry insiders.